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Traditionally hand-pressed argan oil, obtained from Argania spinosa seeds, is eaten raw in south-west Morocco; its rich composition of
tocopherols, MUFA and PUFA make a study of its actions on risk factors for CVD, such as hypertension, interesting. The effects of 7
weeks of treatment with argan oil (10 ml/kg) on the blood pressure and endothelial function of spontaneously hypertensive rats (SHR)
and normotensive Wistar–Kyoto rats were investigated. Systolic blood pressure and heart rate were measured every week by the tail-
cuff method and endothelial function was assessed by carbachol (1028 to 1024 M)-induced relaxations of aortic rings and small mesenteric
arteries pre-contracted with phenylephrine. Argan-oil administration reduced the mean blood pressure of SHR after the fifth week of treat-
ment (P,0·05) and increased (P,0·01) the endothelial responses of arteries from SHR. The NO synthase inhibitor, L-N-v-nitroarginine
(3 £ 1025 M) revealed a greater participation of NO in the relaxant effect after the treatment. When cyclooxygenase (COX) was blocked
with indomethacin (1025 M), an involvement of COX products in the endothelium-dependent response was characterized. Enzyme immu-
noassay of thromboxane B2 showed a significant decrease (P,0·05) in the release of thromboxane A2 in both aorta and small mesenteric
artery after argan-oil treatment of SHR. Experiments in the presence of the thromboxane A2–prostaglandin H2 receptor antagonist ICI
192,605 (1025 M) confirmed this result. Results after incubation with the antioxidants superoxide dismutase and catalase suggested that
a decreased oxidative stress might contribute to explain the beneficial effects of argan-oil treatment.
Argan oil: Hypertension: Endothelium: Cyclooxygenase products: Spontaneously hypertensive rats
There is strong evidence for an association between a
Mediterranean-style diet and protection from CVD (De
Lorgeril et al. 1999). Such a diet lowers total cholesterol
and LDL-cholesterol compared with a diet very rich in
saturated fatty acids, thus reducing a dominant risk factor
for the development of atherosclerosis (Williams, 2001).
Additional mechanisms have favourable effects on other
CVD risk factors, such as hypertension (Simon et al.
1996) and diabetes (Hannah & Howard, 1994; Griffin
et al. 1996). This style of diet, consumed by several differ-
ent populations, has a common characteristic, namely the
high proportion of olive oil (rich in MUFA, mainly oleic
acid; Keys, 1995).
As well as olive oil, there are other vegetable oils that
are sources of dietary unsaturated fatty acids. Argan oil
is traditionally used particularly in Morocco for nutritional
purposes. Traditionally hand-pressed argan oil, obtained
from Argania spinosa seeds, is eaten raw in south-west
Morocco, where it represents 25 % of dietary fat intake
and 9 % of annual production. Argan oil and its prep-
arations have been used in traditional Moroccan medicine
for centuries to cure skin diseases topically. In addition,
argan oil is used orally in rheumatology and is traditionally
prescribed as a choleretic, hepatoprotective agent, and
in cases of hypercholesterolaemia and atherosclerosis
(Charrouf & Guillaume, 1999). However, its potential
biological relevance in cosmetic, pharmaceutical or phyto-
protective fields has yet not been established.
Argan oil is rich in MUFA and PUFA, whereas saturated
fatty acids are present in lower proportions (Charrouf &
Guillaume, 1999). Several studies have suggested that
hypertension and CVD are related to a deficiency in
PUFA, especially of linoleic acid (Das, 1995; Horrobin,
1995), so that an increase in the linoleic acid content of
diet was associated with a decrease in systolic blood press-
ure (Aguila & Mandarin-de-Lacerda, 2000; Yoshioka et al.
2000). Argan oil is also rich in the antioxidant a-toco-
pherol (Charrouf & Guillaume, 1999), which reduced
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blood pressure in an experimental model of hypertension
(Chen et al. 2001). Although a previous report showed
a decrease in blood pressure after ingestion of argan oil
(Berrada et al. 2000), the mechanism involved remains
unknown. Because of the composition of argan oil and
its antihypertensive action, it was of interest to carry out
a deeper study of its cardiovascular effects, focusing on
endothelial function. We have investigated the effect of
chronic treatment with argan oil for 7 weeks on blood
pressure and endothelial dysfunction in spontaneously




Argan oil was extracted by a traditional hand-pressed
method (Charrouf & Guillaume, 1999) from fresh seeds
collected in the same year in order to prevent auto-oxi-
dative reactions. The extraction was carried out in
Essaouira (south-west Morocco).
Animals
Four-week-old male hypertensive SHR (n 12) and normo-
tensive control WKY (n 12) rats, weighing 100–120 g,
were purchased from Harlan Iberica (Barcelona, Spain).
All experiments were performed according to guidelines
for the ethical treatment of animals of the European
Union (86/609/EEC). Both SHR and WKY were divided
randomly into two groups of six animals each: the first
group was fed with standard rat chow (control group;
Panlab SRL, Barcelona, Spain). The second group was
treated with 10 ml argan oil/kg body weight per d intragas-
trically for 7 weeks in addition to the standard diet. This
dose has been shown to have hypolipidaemic and hypocho-
lesterolaemic effects (Berrougui et al. 2003). All the ani-
mals were maintained in a temperature-controlled room
(22 ^ 28C) with a 12 h light–dark cycle and with free
access to standard rat chow and drinking water. The
blood pressure and heart rate of conscious animals were
measured indirectly each week by the tail-cuff method
with a digital pressure meter (Niprem 645; Cibertec,
Madrid, Spain).
Arterial preparation and mounting
The animals were anaesthetized with pentobarbitone
sodium (50 mg/kg intraperitoneally) and exsanguinated.
The thoracic aorta and branch II or III of the small mesen-
teric artery (SMA) were carefully removed and cleaned of
fat and connective tissue. Then, artery segments (2–3 mm
or 1·6–2·0 mm long for the aorta and the SMA respect-
ively) were mounted on myographs filled with physi-
ological salt solution of the following compositions (mM)
for the aorta and SMA respectively: NaCl 119 and 119,
KCl 47 and 47, MgSO4 1·17 and 1·17, KH2PO4 1·18 and
0·40, NaHCO3 25·0 and 14·9, CaCl2 1·8 and 2·5, glucose
11·0 and 5·5. The physiological salt solution was kept con-
tinuously at 378C and gassed with 95 % O2–5 % CO2 at pH
7·4. Resting tension was adjusted to 2 g for the aorta and
200 mg for the SMA. Mechanical activity was recorded
isometrically by a force transducer (Pioden UF-1
(Canterbury, Kent, UK) for the aorta and Multi Myograph
System-610M (Aarhus, Denmark) for the SMA) coupled to
a Powerlabw data acquisition system (AD-Instruments,
Castle Hill, Victoria, Australia). After setting the vessel
to its working length, challenges with 1025 M phenyl-
ephrine (Phen)/l or 1025 M noradrenaline/l were performed
in aorta and SMA respectively to test their maximal
contractile capacity and to elicit a reproducible contracting
response.
Relaxation experiments
Arteries were pre-contracted with Phen: 3 £ 1027 M for the
aorta and 3 £ 1025 M for the SMA. For each preparation, it
was ensured that Phen-induced contractions were stable
during all the experiments. When the contraction reached
a plateau, cumulative addition of carbachol (1028 to
1024 M) was performed. In order to analyse the involvement
of endothelial factors, concentration–response curves were
constructed in the absence or in the presence of the indicated
inhibitor(s): the NO synthase inhibitor, L-N-v-nitroarginine
(L-NOARG; 3 £ 1025 M), the cyclooxygenase (COX)
inhibitor, indomethacin (1025 M), the thromboxane A2–
prostaglandin H2 receptor antagonist ICI 192,605
(1025 M), the superoxide anion (O2
2) scavenger superoxide
dismutase (SOD; 1·5 £ 105 U/l), and catalase (106 U/l). All
the inhibitors were used at a maximally active concentration
and were incubated with the tissue for 20 min before the pre-
contraction with Phen except for SOD þ catalase (i.e.
10 min before pre-contraction with Phen). The concen-
tration of Phen after inhibitors was adjusted in order to
obtain similar pre-contraction levels.
Thromboxane A2 production
Thromboxane (TX) A2 is instable and is quickly converted
to TXB2. Intact aortas and mesenteric bed from control and
argan oil-treated SHR were incubated in physiological salt
solution at 378C and bubbled with a 95 % O2–5 % CO2 gas
mixture and stimulated with Phen (1026 M for aorta and
1025 M for SMA) and carbachol (1026 M) to liberate to
the medium vasoactive products. The concentration of
TXB2 was assessed by competitive enzyme immunoassay
kits (Cayman Chemical Company, Ann Arbor, MI,
USA). TXB2 production was expressed as pg/mg dry
tissue.
Chemical reagents and drugs
Acetylcholine chloride, indomethacin, L-NOARG, phenyl-
ephrine hydrochloride, carbachol chloride, catalase and
SOD were purchased from Sigma Chemical Co. (St
Louis, MO, USA). ICI 192,605 was purchased from
Tocris (Biogen Cientifica S.L., Madrid, Spain). The drugs
were dissolved in distilled and deionized water except for
indomethacin and ICI 192,605, which were dissolved in
dimethylsulfoxide. The final concentration of dimethylsulf-
oxide in the tissue bath was 0·1 g/l, which was shown to
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have no effect on the basal tonus of the preparation. All
concentrations of the drugs used are expressed as final
concentration in the organ chamber.
Statistical analysis
Results were expressed as a percentage from the initial pre-
contraction level and as mean values with their standard
errors for six determinations obtained from different ani-
mals. The pre-contraction levels of the arteries from the
four groups of animals are summarized in Table 1. Areas
under concentration–response to carbachol curves were
calculated in the absence of inhibitors and in the presence
of indomethacin or L-NOARG. In order to evaluate the
approximate participation of COX products and NO, the
subtraction area under control curve minus area in the pre-
sence of indomethacin or L-NOARG was calculated. A
positive sign (þ ) in the result was interpreted as the preva-
lence of a relaxant factor and the negative (2 ) sign as a
greater involvement of contracting products. ANOVA fol-
lowed by Tukey’s multiple comparisons test was used for
statistical analysis. P values ,0·05 were considered to
show a significant difference. Statview software package
(version 5.0; SAS Institute Inc., Cary, NY, USA) was
used to carry out statistical analysis.
Results
Blood pressure
Daily argan-oil administration induced a progressive
reduction in mean blood pressure in SHR; this reduction
was significant from the fifth week of treatment
(P,0·05; Fig. 1). However, no change was observed in
blood pressure of normotensive WKY during the 7 weeks
of treatment with argan oil. Despite the decrease in blood
pressure in SHR, the heart rate was not affected by treat-
ment in either group (377·4 (SEM 11·6) and 388·8 (SEM
14·5) beats per min in WKY control and treated groups
respectively; 429·6 (SEM 10·9) in SHR control and 406·1
(SEM 9·11) beats per min after treatment).
Although animals were treated with 1 ml fatty com-
pound/d, body weight was not affected (303·7 (SEM 6·8)
and 284·7 (SEM 18·2) g for WKY control and treated
groups respectively; 276·2 (SEM 6·8) and 258·7 (SEM
18·2) g for control and treated SHR groups respectively).
Endothelium-dependent relaxation
Endothelial function was assessed in two different vascular
beds by relaxation induced by carbachol in arteries pre-
contracted by Phen. After the 7-week treatment with
argan oil, the concentration–response curves to carbachol
of aortas and SMA from normotensive WKY were not sig-
nificantly affected (Fig. 2(A and B)). In contrast, the endo-
thelium-dependent relaxation of aortic rings from argan
oil-treated SHR was significantly increased (P,0·01) com-
pared with that of the SHR control group (Fig. 2(C)). The
maximal relaxant response reached in SHR after treatment
(83·7 (SEM 2·8) %) was even greater than that obtained in
normotensive WKY (65·7 (SEM 8·6) %, P,0·001).
In SMA from SHR, the relaxation–response curve to
carbachol had a biphasic profile with contraction induced
by carbachol at concentration .1026 M. Although maxi-
mal relaxation to carbachol was significantly increased
by argan-oil treatment, this biphasic profile of the curve
was not altered (Fig. 2(D)).
Characterization of endothelial factors involved
The effect of the NO-synthase inhibitor L-NOARG was
studied in order to find out whether NO was involved in
the improvement of endothelial relaxation in aortae and
SMA. In both types of arteries L-NOARG (3 £ 1025 M)
produced a statistically significant blockade of the relax-
ation in non-treated rats (Fig. 3(A and C), aorta; Fig. 4(A
and C), SMA) and argan oil-treated rats (Fig. 3(B and D),
aorta; Fig. 4(B and D), SMA).
Table 1. Contractile effect of phenylephrine (g) in aortic
rings and superior mesenteric arteries (SMA) from control
and argan (Argania spinosa) oil-treated Wistar–Kyoto and
spontaneously hypertensive rats†
(Mean values with their standard errors)
WKY SHR
Mean SEM Mean SEM
Aorta Control 2·10 0·04 1·41* 0·09
Argan oil 1·54 0·10 1·54 0·10
SMA Control 0·93 0·11 1·29 0·23
Argan oil 1·18 0·04 1·28 0·15
WKY, Wistar–Kyoto rats; SHR, spontaneously hypertensive rats.
* Mean value was significantly different from that of the control
WKY group: *P,0·05.
† For details of treatments and procedures, see p. 922.
Fig. 1. Effect of argan (Argania spinosa)-oil treatment on blood
pressure (mmHg) in normotensive Wistar–Kyoto rats (WKY; O) and
spontaneously hypertensive rats (SHR; †). Results were compared
with age- and strain-matched control animals (WKY (K) and SHR
(W)). For details of treatments and procedures, see p. 922. Values
are means with their standard errors shown by vertical bars. Mean
values were significantly different from those of the control group:
*P,0·05, **P,0·01. Mean values for the normotensive WKY were
significantly different from those of the hypertensive SHR without
treatment: ††P,0·01, †††P,0·001.
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Fig. 2. Endothelial function assessed by relaxant response to carbachol (CCh; 1028 to 1024 M) of isolated rat aortic rings (A and C) and small
mesenteric artery (B and D) from normotensive Wistar–Kyoto rats (A and B) and spontaneously hypertensive rats (C and D). Results obtained
from argan (Argania spinosa) oil-treated animals (†) were compared with age- and strain-matched animals (W). For details of treatments and
procedures, see p. 922. Values are means with their standard errors shown by vertical bars. Mean values for argan-oil treated animals were
significantly different from those of the control group: *P,0·05, **P,0·01.
Fig. 3. Characterization of endothelial factors released after stimulation with carbachol (CCh; 1028 to 1024 M) of aortic rings from non-treated
Wistar–Kyoto rats (WKY) (A), argan (Argania spinosa) oil-treated WKY (B), non-treated spontaneously hypertensive rats (SHR) (C) and argan
oil-treated SHR (D). Concentration–response curves constructed in the absence of inhibitors were considered as control curves (W) and
compared with those made in the presence of L-N-v-nitroarginine (L-NOARG; 3 £ 1025 M) (†), indomethacin (1025 M) (O) or indomethacin plus
L-NOARG (K). For details of treatments and procedures, see p. 922. Values are means with their standard errors shown by vertical
bars. Mean values were significantly different from those of the control curve: *P,0·05, **P,0·01. Mean values for SHR were significantly
different from those of WKY: †††P,0·001. Mean values for L-NOARG were significantly different from those of L-NOARG plus indomethacin:
‡P,0·05.
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In order to study the involvement of COX products in
endothelial relaxation, arteries were incubated in the pre-
sence of a non-selective COX inhibitor, indomethacin
(1025 M). This drug did not modify carbachol-induced
relaxation of aortic rings from WKY. In aortas from con-
trol SHR, indomethacin increased the relaxant response,
although this effect was not significant. With regard to
SHR treated with argan oil, the presence of indomethacin
did not affect the concentration–response curve of aortic
rings. In resistance arteries from SHR, indomethacin sig-
nificantly increased carbachol-induced relaxation
(P,0·01) and abolished the biphasic profile of the control
curve (Fig. 4(C and D)).
Exposure to indomethacin (1025 M) plus L-NOARG
(3 £ 1025 M) completely abolished (P,0·01) the carba-
chol-induced relaxation curve in rat aorta and SMA
(Figs 3 and 4). In aortic rings from treated SHR, the inhi-
bition obtained after incubation with indomethacin plus
L-NOARG was significantly greater than that achieved
in the presence of L-NOARG (P,0·05; Fig. 3(D)).
The presence of a relaxant COX-product in aortic rings
after argan-oil administration could well explain this
result. However, in SMA from non-treated SHR, the
greater relaxation in the presence of L-NOARG plus indo-
methacin than in the presence of L-NOARG (P,0·05;
Fig. 4(C)) could be attributed to the presence of COX-
derived contracting products in hypertensive rats.
In order to illustrate better the contribution of endo-
thelium-derived factors in the relaxation induced by carba-
chol, areas under concentration–response curves were
calculated in the absence and in the presence of L-NOARG
and indomethacin, representing NO and COX products
respectively. The calculated participation of NO in the
carbachol-induced relaxation of isolated aorta from argan
oil-treated rats was greater (P,0·05 in WKY; P,0·001 in
SHR) than in aortic rings from untreated rats. With regard
to the COX products released in isolated aorta, the resulting
contracting effect was found in SHR, but not in WKY, where
relaxant factors derived from COX had a greater involve-
ment (Fig. 5(A)). The treatment with argan oil decreased
the participation of COX products in aortic rings from
SHR (P,0·05) without affecting the sign of the calculated
value (Fig. 5(A)).
In SMA, the participation of NO was significantly
greater after argan-oil treatment in SHR (P,0·01) but
not in normotensive WKY. According to the results
observed in the aorta, the involvement of contracting
COX products was also decreased in SMA from SHR
after treatment (P,0·05). However, the prevalence of con-
tracting COX products was found in SMA from treated
WKY (P,0·05; Fig. 5(B)).
To verify the nature of endothelial vasoconstrictor pro-
ducts from the COX involved, the effect of the TXA2–pros-
taglandin H2 receptor antagonist, ICI 192,605 (10
25
M) on
carbachol-induced relaxation in arteries from SHR was
investigated. Though the relaxation of arteries from non-
treated SHR was enhanced by incubation with ICI 192,605
(Fig. 6(A and C)), this increase was not statistically differ-
ent. In aortic rings from argan-oil treated SHR, the presence
of ICI 192,605 did not affect the relaxant response to carba-
chol. This antagonist significantly inhibited the relaxation in
SMA from treated SHR (P,0·05; Fig. 6(D)).
Fig. 4. Characterization of endothelial factors released after stimulation with carbachol (CCh; 1028 to 1024 M) of small mesenteric arteries from
non-treated Wistar–Kyoto rats (WKY) (A), argan (Argania spinosa) oil-treated WKY (B), non-treated spontaneously hypertensive rats (SHR)
(C) and argan oil-treated SHR (D). Concentration–response curves constructed in the absence of inhibitors were considered as control curves
(W) and compared with those made in the presence of L-N-v-nitroarginine (L-NOARG) (3 £ 1025 M; †), indomethacin (1025 M; D) or indo-
methacin plus L-NOARG (K). For details of treatments and procedures, see p. 922. Values are means with their standard errors shown by ver-
tical bars. Mean values were significantly different from those of the control curve: *P,0·05, **P,0·01. Mean value for L-NOARG was
significantly different from that of L-NOARG plus indomethacin: †P,0·05.
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The TXB2 levels released by stimulated aortic rings and
mesenteric bed from non-treated SHR were 312·66 (SEM
39·47) (n 4) and 157·49 (SEM 22·93) (n 4) pg/mg respect-
ively. After 7-weeks treatment with argan oil, the release
of TXB2 decreased significantly in aortic rings (193·61
(SEM 22·10) pg/mg (n 4), P,0·05) and mesenteric bed
(92·84 (SEM 2·34) pg/mg (n 4), P,0·05).
Involvement of oxygen free radicals in the effect of argan
oil on endothelial function
Finally, to investigate whether an augmented production of
O2
2 was involved, the effect of SOD was studied in SHR.
In both isolated rat aorta and SMA the presence of SOD
plus catalase significantly increased (P,0·05) the carba-
chol-induced relaxation in untreated rats, since SHR are
rich in free radicals derived from O2. After argan oil
administration, the endothelium-dependent relaxation of
aortic ring was not increased by the presence of antioxidant
enzymes (Fig. 7(B)). When the same experiment was car-
ried out on SMA from treated animals, the presence of
SOD plus catalase increased the contraction phase of the
concentration–response curve (Fig. 7(D); P,0·01).
Discussion
Dietary fatty acids have been reported to influence the
development of hypertension and vascular reactivity of
both resistance and large conductance arteries (Schmidt,
1997; Angerer & Von Shacky, 2000). The preventive
effects of PUFA such as linoleic and g-linolenic acid on
hypertension are well known, whereas saturated fatty
acids have been shown to promote hypertension (Aguila
& Mandarin-de-Lacerda, 2000; Yoshioka et al. 2000).
Changes in lipid metabolism caused by a diet rich in mono-
unsaturated oleic acid that could be favourable in the pre-
vention of atherosclerosis and thrombosis have been
observed (Williams, 2001). In the present study, the effects
of argan-oil ingestion on blood pressure and endothelial
function were evaluated.
In relation to the chemical composition of argan oil,
unsaturated fatty acids are the major components (oleic
plus linoleic acids constitute 80 g/100 g total fatty acids)
and linolenic acid is only present as a trace (Charrouf
& Guillaume, 1999). Argan oil is about twice as rich in
tocopherol as olive oil (620 v. 320 mg/kg); tocopherol is
present mainly as a-tocopherol (69 %). This compound, a
known antioxidative agent, makes argan oil a very import-
ant source of vitamin E and is probably responsible for the
good keeping qualities of the oil (Chimi et al. 1994). In
addition to PUFA, antioxidants such as a-tocopherol and
vitamin C are known to prevent development of hyperten-
sion (Newaz & Nawal, 1998; Newaz et al. 1999) and endo-
thelial dysfunction in SHR (Abeywardena & Head, 2001;
Chen et al. 2001).
We have shown that chronic treatment with argan oil
prevented the development of hypertension in this animal
model (SHR), substantially modifying mean blood pressure
from the fifth week of treatment without altering heart rate
and body weight. Taking into account the composition of
argan oil, two hypotheses could be put forward. First, the
high proportion of the PUFA linoleic acid present in
argan oil could play a role in blood pressure regulation.
It has been demonstrated that plasma concentration of
linoleic acid is inversely associated with blood pressure
(Grimsgaard et al. 1999) and that diets enriched with
linoleic or g-linolenic acid attenuated the development
of hypertension in SHR (Abeywardena & Head, 2001;
Frenoux et al. 2001). The second hypothesis to consider
is that the high proportion of a-tocopherol present in
argan oil could be related to the antihypertensive effect
observed. Thus, the dose of a-tocopherol administered in
the argan oil to rats (3·8 mg/kg per d) was similar to the
dose that has previously demonstrated prevention of high
blood pressure in SHR (Newaz & Nawal, 1998; Newaz
et al. 1999).
Regarding the improvement of endothelial dysfunction
of SHR, pharmacological tools were used to evaluate the
Fig. 5. Contribution of NO (A) and cyclooxygenase (B) products to
the endothelial response to carbachol in aortic rings (A) and small
mesenteric arteries (SMA) (B). AUC, area under the curve; WKY,
Wistar–Kyoto rat; SHR; spontaneously hypertensive rat; c, control;
argan, argan (Argania spinosa) oil-treated. Values were calculated
by the difference between AUC in the absence of inhibitors minus
AUC in the presence of L-N-v-nitroarginine or indomethacin. AUC
.0 means that the released products induce a relaxation. If AUC
,0, products promote contraction. For details of treatments and
procedures, see p. 922. Values are means with their standard
errors shown by vertical bars. Mean values for argan oil-treated rats
were significantly different from those of the non-treated group of
the same strain: *P,0·05; **P,0·01, ***P,0·001.
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relative contribution of different endothelial factors to this
effect. The presence of a NO synthase inhibitor revealed an
increased participation of NO in relaxation induced by car-
bachol. In order to explain this increase of NO-dependent
relaxation, the antioxidant properties of argan oil due to
a high concentration of the antioxidant vitamin a-toco-
pherol should be noted. It has been shown previously
that the oxidative stress in SHR could be decreased after
treatment with vitamin E (Newaz & Nawal, 1998). Those
animals receiving a-tocopherol elicited a lower release of
Fig. 6. Effect of the Tp receptor antagonist, ICI 192,605 (1025 M) on the carbachol (CCh)-induced relaxation of aortic rings (A and B) on
small mesenteric arteries (C and D) of non-treated spontaneously hypertensive rats (SHR) (A and C) and argan oil-treated SHR (B and D).
†, Concentration–response curve made in the presence of ICI 192,605; W, control curve in the absence of any inhibitor. For details of treat-
ments and procedures, see p. 922. Values are means with their standard errors shown by vertical bars. Mean value was significantly different
from that of the control curve: *P,0·05.
Fig. 7. Effect of the antioxidant enzymes superoxide dismutase (SOD; 150 U/ml) plus catalase (1000 U/ml) on the carbachol (CCh)-induced
relaxation of aortic rings (A and B) on small mesenteric arteries (C and D) of non-treated spontaneously hypertensive rats (SHR) (A and C)
and argan (Argania spinosa) oil-treated SHR (B and D). (†), Concentration–response curve made in the presence of SOD plus catalase; (W),
control curve in the absence of any inhibitor. For details of treatments and procedures, see p. 922. Values are means with their standard errors
shown by vertical bars. Mean values were significantly different from those of the control curve: *P,0·05, **P,0·01.
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anion superoxide and consequently endothelial response
improved (Chen et al. 2001). The anion superoxide
reacts quickly with NO to produce peroxynitrite, which
does not have the same vasodilator and anti-aggregating
properties (Gryglewski et al. 1986). Besides this, a-toco-
pherol is reported to increase NO synthase activity by a
mechanism involving free radicals and concomitantly
reduces the blood pressure (Newaz et al. 1999). In this
way, a lower oxidative status of SHR due to the antioxi-
dants present in argan oil could improve bioavailability
of NO by both decreasing its breakdown and increasing
its synthesis. To confirm this hypothesis experiments in
the presence of antioxidant enzymes were carried out.
The endothelial relaxation of both aortic rings and SMA
after incubation with SOD plus catalase was improved in
control animals. This increase in endothelial response
after incubation with the antioxidant enzymes was due to
an improved oxidant status, as previously demonstrated
by our research group (Carneado et al. 2002). However,
the presence of SOD plus catalase did not alter the concen-
tration–response curve in aorta from treated animals, prob-
ably because of a lower release of superoxide or an
increase in antioxidant defence after treatment with the
oil. In SMA, the presence of SOD plus catalase even inhib-
ited relaxation. This inhibitory effect on endothelium-
dependent relaxation could be related to a high concen-
tration of SOD that blunted endothelial NO. However, it
is possible that reactive oxygen species were playing a
role in the increase of endothelium-dependent relaxation
of SMA after treatment with argan oil. In this way, it has
been shown previously that O2
2 could enhance Ca2þ–NO
signalling in endothelial cells (Graier et al. 1996) and
even stimulate those cells to produce NO (Dreher et al.
1995; Hu et al. 1998).
In addition to NO, the participation of COX-derived pro-
ducts in the effect of argan oil was studied. The presence of
the COX inhibitor, indomethacin, revealed a decrease in
the resulting COX contracting component. To explain
this result, the minor involvement of vasoconstrictor
TXA2 and prostaglandin H2 and/or an increase in vasodila-
tor prostaglandin I2 should be noted. The enzyme inmu-
noassay confirmed that after treatment with argan oil the
TXA2 released by either aortic rings or SMA was signifi-
cantly reduced. This result agrees with those shown in
the presence of ICI 192,605 in aortic rings. In these
arteries, the TXA2–prostaglandin H2 Tp receptor antagon-
ist improved relaxation only in non-treated SHR. However,
in aorta we cannot exclude a greater participation of a
relaxant derived from COX after treatment with argan
oil, since the presence of indomethacin plus L-NOARG
was significantly more effective than L-NOARG alone in
inhibiting relaxation. Regarding resistance arteries, the
main factor involved in endothelial dysfunction does
not act through the receptor antagonized by ICI 192,605.
Vascular bed heterogeneity with regard to eicosanoids
released by the endothelium is also described in endothelial
dysfunction due to ageing (Matz et al. 2000) where COX
products related to endothelial dysfunction of SMA were
different from TXA2 and remain unindentified. Although
it was not the responsible for endothelial dysfunction,
TXA2 production decreased after treatment with argan
oil. This could be related to the inhibition of the carba-
chol-induced response after incubation with ICI 192,605
in SMA from treated SHR.
Another relevant fact was that involvement of COX pro-
ducts turned into a greater contracting component in SMA
from treated WKY without increase in blood pressure. It
has been reported that the two strains of rat differ in
their fatty acid metabolism (Mills et al. 1990) and their
vascular responses after diets enriched in PUFA were
altered in different ways (Engler et al. 1992). Those differ-
ences in metabolism between the strains may help to
explain the opposing endothelial response after COX inhi-
bition. In addition to the previously discussed antioxidant
properties of argan oil, its richness in linoleic acid could
be related to the effect on endothelial COX products.
Some studies suggest that linoleic acid could both increase
synthesis of vasoactive prostaglandins (Calder, 1997) and
decrease TX production (Engler, 1996).
In conclusion, treatment of hypertensive animals with
argan oil not only prevented the increase in blood pressure,
but also improved endothelial function. A high concen-
tration of linoleic acid and a-tocopherol could contribute
to explaining this effect that was dependent on both
COX products and NO. However, further studies should
be done in order to identify the mechanisms of the effects
of argan oil on endothelium as well as its mechanism of
action. Although the present study supports the use of
this oil in the diet and as a dietary supplement, the concen-
tration used in the present study was higher than normal
human consumption. Clinical research should be done
before validating its use to improve endothelial dysfunction
and hypertension.
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